Nwam LLC Purchases New Stake in Ventas, Inc. $VTR

Nwam LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTR) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 8,880 shares of the real estate investment trust’s stock, valued at approximately $625,000.

A number of other large investors also recently added to or reduced their stakes in VTR. Norges Bank acquired a new stake in shares of Ventas during the 2nd quarter worth approximately $344,740,000. Vanguard Group Inc. boosted its stake in Ventas by 4.1% in the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after acquiring an additional 2,854,751 shares during the last quarter. Citigroup Inc. boosted its stake in Ventas by 451.9% in the second quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after acquiring an additional 1,896,627 shares during the last quarter. State Street Corp grew its holdings in Ventas by 5.2% during the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after acquiring an additional 1,388,678 shares during the period. Finally, Invesco Ltd. raised its position in shares of Ventas by 36.1% during the 2nd quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock valued at $303,939,000 after acquiring an additional 1,275,446 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Ventas

In related news, CFO Robert F. Probst sold 33,591 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the completion of the transaction, the chief financial officer directly owned 168,364 shares in the company, valued at approximately $12,925,304.28. This trade represents a 16.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Peter J. Bulgarelli sold 3,924 shares of Ventas stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $75.00, for a total value of $294,300.00. Following the completion of the sale, the chief executive officer directly owned 112,564 shares in the company, valued at approximately $8,442,300. This represents a 3.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 713,520 shares of company stock valued at $52,788,577 over the last three months. Company insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

VTR has been the topic of several recent research reports. Scotiabank raised their price target on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. KeyCorp increased their target price on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Wells Fargo & Company boosted their target price on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $93.00 price target on shares of Ventas in a research note on Monday, December 15th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, January 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.63.

Ventas Price Performance

NYSE VTR opened at $78.40 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.32 and a current ratio of 0.32. The stock has a market cap of $36.82 billion, a price-to-earnings ratio of 150.76, a PEG ratio of 1.94 and a beta of 0.78. The business has a 50 day simple moving average of $78.44 and a 200 day simple moving average of $71.85. Ventas, Inc. has a 52-week low of $58.22 and a 52-week high of $81.89.

Ventas (NYSE:VTR) last released its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter in the prior year, the company earned $0.80 earnings per share. The business’s quarterly revenue was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Analysts anticipate that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Wednesday, December 31st. Ventas’s payout ratio is 369.23%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.